Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

5.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful long-term remission of hyperchylomicronemia caused by GPIHBP1 autoantibodies: With insights into antibody epitope effects.

Journal of clinical lipidology·2026
Same author

Autoantibodies against adenosine deaminase acting on RNA1 (ADAR1) in patients with systemic lupus erythematosus: its relationship to clinical features and other autoantibodies.

Modern rheumatology·2026
Same author

Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.

Immunological medicine·2026
Same author

Synovial Fluid Cell Profiling Identifies Distinct Inflammatory Phenotypes in Late-Onset Rheumatoid Arthritis and Polymyalgia Rheumatica.

ACR open rheumatology·2026
Same author

A kidney-protective mechanism via cellular oxidative stress reduction induced by CD5L protein.

Cell death discovery·2026
Same author

Apoptosis Inhibitor of Macrophage and Acute Inflammation in IgA Nephropathy.

Kidney360·2026

Related Experiment Video

Updated: May 11, 2025

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.4K

Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and

Aya Shimizu1, Kazuhiro Kurasawa2, Tomoka Hiyama1

  • 1Department of Rheumatology, Dokkyo Medical University, 880 Kita-Kobayashi, Mibu, Tochigi, 321-0293, Japan.

Arthritis Research & Therapy
|April 16, 2025
PubMed
Summary

Two distinct pathways link cytokine abnormalities to mortality in patients with anti-melanoma differentiation-associated protein 5 antibodies (anti-MDA5 Ab). These pathways involve specific inflammatory markers and contribute to poor prognosis, aiding in risk stratification.

Keywords:
Anti-MDA5 antibodyCytokinesDermatomyositisGroupingInterstitial lung diseasePrediction modelPrognostic factors

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

23.9K

Related Experiment Videos

Last Updated: May 11, 2025

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
08:00

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

7.4K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies
09:32

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

23.9K

Area of Science:

  • Rheumatology
  • Immunology
  • Pulmonology

Background:

  • Anti-melanoma differentiation-associated protein 5 antibodies (anti-MDA5 Ab) are associated with interstitial lung disease (ILD) and poor prognosis.
  • Understanding the mechanisms linking cytokine dysregulation to mortality in these patients is crucial for improving outcomes.

Purpose of the Study:

  • To identify distinct pathways connecting cytokine abnormalities to mortality through prognostic factors in patients with anti-MDA5 Ab.
  • To develop a predictive model for prognosis based on identified factors.

Main Methods:

  • Serum cytokine levels were measured in anti-MDA5 Ab-positive patients.
  • Prognostic factors and their groupings were identified using statistical analyses including Cox regression, log-rank test, principal component analysis (PCA), and cluster analysis.
  • Path analysis explored associations between cytokines and prognostic factor groups.

Main Results:

  • Thirty-five patients were analyzed; 31 had rapidly progressive interstitial lung disease (RP-ILD), and 14 died.
  • Key prognostic factors included inflammatory markers (WBC, CRP, ferritin, LDH, γ-GTP) and ILD-specific markers (KL-6, SP-D, CT score).
  • Two prognostic groups emerged: Group 1 (WBC, CRP, ILD factors) linked to IL-6, and Group 2 (ferritin, LDH, γ-GTP) linked to IL-6, IL-10, IP-10, and TNF-α. A model using CRP and γ-GTP showed good predictive performance (AUC=0.84).

Conclusions:

  • Two distinct pathways associated with specific cytokine abnormalities contribute to mortality in anti-MDA5 Ab-positive patients.
  • These findings elucidate the complex interplay between inflammation, ILD, and prognosis in this patient cohort.
  • The identified prognostic factors and pathways offer potential targets for therapeutic intervention and improved risk stratification.